Clinical Trial Update: A Study to Evaluate the Safety of Fycompa Injection in Participants With Partial-Onset Seizures or Primary Generalized Tonic- Clonic Seizures

View source ↗

Summary

A clinical trial update describing a study to evaluate the safety of Fycompa Injection (perampanel) in participants with partial-onset seizures or primary gener…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Tonic-clonic Seizures
• Partial-onset Seizures

Drugs mentioned

• Fycompa (perampanel)

Snippet

Sponsor: Eisai Co., Ltd. | Conditions: Partial-Onset Seizures, Primary Generalized Tonic-clonic Seizures | Status: RECRUITING